Literature DB >> 24594052

Efficient ELISA for diagnosis of active tuberculosis employing a cocktail of secretory proteins of Mycobacterium tuberculosis.

D Tiwari1, R P Tiwari2, R Chandra1, P S Bisen3, S Haque4.   

Abstract

Rapid and accurate diagnosis is important for preventing transmission of Mycobacterium tuberculosis. Currently available tuberculosis (TB) diagnostic methods lack desired sensitivity and specificity, and require sophisticated equipment and skilled workforce including weeks' long duration to yield results. In this study, extracellular proteins or secretory protein antigens of M. tuberculosis H37Rv have been isolated using ion exchange chromatography, immunocharacterized and exploited for the development of efficient enzyme-linked immunosorbent assay (ELISA) for diagnosis of active TB with enhanced specificity and sensitivity. Apparent molecular masses for purified proteins were found to be 6, 27, 30, 38 and 64 kDa. Out of five purified proteins, one (64 kDa) was found to be novel. Of the five proteins, four (6, 27, 30 and 38 kDa) were found significant to be used in the development of ELISA for pulmonary and extra-pulmonary TB. The immune responses of serum samples of TB patients and other healthy subjects against the above-mentioned antigens' cocktail were evaluated. Critical parameters of newly developed ELISA were optimized and it was observed that the cocktail antigens have a greater specificity (98.06 %) and sensitivity (98.67 %) as compared to other commercially available diagnostic tests. The present findings suggest that the developed ELISA is an effective tool for routine screening and early-stage diagnosis of TB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24594052

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  7 in total

1.  High-throughput Identification of DNA-Encoded IgG Ligands that Distinguish Active and Latent Mycobacterium tuberculosis Infections.

Authors:  Kimberly R Mendes; Marie Lynne Malone; John Maina Ndungu; Irena Suponitsky-Kroyter; Valerie J Cavett; Patrick J McEnaney; Andrew B MacConnell; Todd M Doran; Katharina Ronacher; Kim Stanley; Ofelia Utset; Gerhard Walzl; Brian M Paegel; Thomas Kodadek
Journal:  ACS Chem Biol       Date:  2016-12-13       Impact factor: 5.100

2.  Detection of Tuberculosis in HIV Co-infected Individuals: Use of Multiple ELISA Responses to 38kDa, Lipoarabinomannan and ESAT- 6 of M. tuberculosis.

Authors:  Ravi Gutlapalli; Aparna Sykam; Sandeep P Tenali; Priscilla Chandran; Sujai Suneetha; Lavanya M Suneetha
Journal:  J Clin Diagn Res       Date:  2016-02-01

Review 3.  Anything You Can Do, I Can Do Better: Can Aptamers Replace Antibodies in Clinical Diagnostic Applications?

Authors:  Michelle Bauer; Mia Strom; David S Hammond; Sarah Shigdar
Journal:  Molecules       Date:  2019-11-30       Impact factor: 4.411

4.  Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection.

Authors:  Caiqin Zhang; Xiaoqin Song; Yong Zhao; Hai Zhang; Shanmin Zhao; Fengfeng Mao; Bing Bai; Shaoping Wu; Changhong Shi
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

Review 5.  A systematic review of potential screening biomarkers for active TB disease.

Authors:  James H Wykowski; Chris Phillips; Thao Ngo; Paul K Drain
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-11-05

Review 6.  Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation.

Authors:  Khalid Ahmed Al-Anazi; Asma Marzouq Al-Jasser; Khalid Alsaleh
Journal:  Front Oncol       Date:  2014-08-26       Impact factor: 6.244

Review 7.  Role of alpha-crystallin, early-secreted antigenic target 6-kDa protein and culture filtrate protein 10 as novel diagnostic markers in osteoarticular tuberculosis.

Authors:  Nazia Rizvi; Ajai Singh; Manish Yadav; Syed Rizwan Hussain; Salma Siddiqui; Vineet Kumar; Sabir Ali; Avinash Agarwal
Journal:  J Orthop Translat       Date:  2016-01-25       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.